Accounts Receivable, after Allowance for Credit Loss, Current of Merck & Co., Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Merck & Co., Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Merck & Co., Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $11,775,000,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Merck & Co., Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $11,775,000,000 +$1,497,000,000 +15% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $12,120,000,000 +$739,000,000 +6.5% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $11,846,000,000 +$204,000,000 +1.8% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $10,790,000,000 -$576,000,000 -5.1% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $10,278,000,000 -$71,000,000 -0.69% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $11,381,000,000 +$987,000,000 +9.5% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $11,642,000,000 +$612,000,000 +5.5% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $11,366,000,000 +$951,000,000 +9.1% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $10,349,000,000 +$899,000,000 +9.5% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $10,394,000,000 +$912,000,000 +9.6% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $11,030,000,000 +$1,387,000,000 +14% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $10,415,000,000 +$587,000,000 +6% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $9,450,000,000 +$220,000,000 +2.4% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $9,482,000,000 +$911,000,000 +11% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $9,643,000,000 +$1,800,000,000 +23% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $9,828,000,000 +$1,593,000,000 +19% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $9,230,000,000 +$2,427,000,000 +36% 31 Dec 2021 10-K 24 Feb 2023 2022 FY
Q3 2021 $8,571,000,000 +$149,000,000 +1.8% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $7,843,000,000 +$266,000,000 +3.5% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $8,235,000,000 +$53,000,000 +0.65% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $6,803,000,000 +$25,000,000 +0.37% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $8,422,000,000 -$20,000,000 -0.24% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $7,577,000,000 -$387,000,000 -4.9% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $8,182,000,000 +$574,000,000 +7.5% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $6,778,000,000 -$293,000,000 -4.1% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $8,442,000,000 +$1,068,000,000 +14% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $7,964,000,000 +$677,000,000 +9.3% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $7,608,000,000 +$363,000,000 +5% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $7,071,000,000 +$198,000,000 +2.9% 31 Dec 2018 10-K 26 Feb 2020 2019 FY
Q3 2018 $7,374,000,000 -$297,000,000 -3.9% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $7,287,000,000 -$152,000,000 -2% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $7,245,000,000 +$179,000,000 +2.5% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $6,873,000,000 -$145,000,000 -2.1% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $7,671,000,000 +$307,000,000 +4.2% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $7,439,000,000 +$523,000,000 +7.6% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 $7,066,000,000 +$216,000,000 +3.2% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 $7,018,000,000 +$534,000,000 +8.2% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $7,364,000,000 +$950,000,000 +15% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 $6,916,000,000 +$406,000,000 +6.2% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $6,850,000,000 +$180,000,000 +2.7% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 $6,484,000,000 -$142,000,000 -2.1% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $6,414,000,000 -$101,000,000 -1.6% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $6,510,000,000 -$512,000,000 -7.3% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 $6,670,000,000 -$518,000,000 -7.2% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 $6,626,000,000 -$558,000,000 -7.8% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 $6,515,000,000 -$1,063,000,000 -14% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $7,022,000,000 -$757,000,000 -9.7% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $7,188,000,000 -$777,000,000 -9.8% 31 Mar 2014 10-Q 08 May 2014 2014 Q1
Q4 2013 $7,184,000,000 -$488,000,000 -6.4% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q3 2013 $7,578,000,000 -$374,000,000 -4.7% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $7,779,000,000 -$373,000,000 -4.6% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 $7,965,000,000 -$761,000,000 -8.7% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $7,672,000,000 -$589,000,000 -7.1% 31 Dec 2012 10-K 27 Feb 2014 2013 FY
Q3 2012 $7,952,000,000 -$184,000,000 -2.3% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $8,152,000,000 -$323,000,000 -3.8% 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $8,726,000,000 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 $8,261,000,000 +$917,000,000 +12% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q3 2011 $8,136,000,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $8,475,000,000 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q4 2010 $7,344,000,000 31 Dec 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.